✦ LIBER ✦
Daily (D) vs. twice-daily (BID) thoracic irradiation (TI) with concurrent cisplatinietoposide (PE) chemotherapy as initial therapy for patients with limited small cell lung cancer (LSCLC): Preliminary results of a phase III prospective intergroup trial
✍ Scribed by H. Wagner; K. Kim; D.H. Johnson; R. Komaki; W. Sause; W. Curran; R. Livingston; A.T. Turrisi III
- Publisher
- Elsevier Science
- Year
- 1994
- Tongue
- English
- Weight
- 144 KB
- Volume
- 30
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.